Tingting Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Tingting Ding has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Hua Lu
Sch. of Med., Shanghai Jiaotong Univ., Shanghai, China
1 shared publicationJiao Sun
Sch. of Med., Shanghai Jiaotong Univ., Shanghai, China
1 shared publication- Jiao Sun
Associated Engineering Research Center of Mechanics and Mechatronic Equipment, Shandong University, Weihai 264209, China
1 shared publication - Xin Liu
Shanghai Biomaterials Research & Testing Center, Shanghai Key Laboratory of Stomatology, Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, No. 427, Ju-men Road, Shanghai, 200023, China
1 shared publication Yang Xue
Sch. of Med., Shanghai Jiaotong Univ., Shanghai, China
1 shared publication- Yang Xue
Shanghai Biomaterials Research & Testing Center, Shanghai Key Laboratory of Stomatology, Ninth People’s Hospital, Shanghai Jiaotong University School of Medicine, No. 427, Ju-men Road, Shanghai, 200023, China
1 shared publication
Latest Publications
- Open Access
- 18 September 2012
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 9 (1) , 36
Enhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions
Background: Inorganic particles, such as drug carriers or contrast agents, are often introduced into the vascular system. Many key components of the in vivo vascular environment include monocyte-endothelial cell interactions, which are important in the initiation of cardiovascular disease. To better understand the effect of particles on vascular function, the present study explored the direct biological effects of particles on human umbilical vein endothelial cells (HUVECs) and monocytes (THP-1 cells). In addition, the integrated effects and possible mechanism of particle-mediated monocyte-endothelial cell interactions were investigated using a coculture model of HUVECs and THP-1 cells. Fe3O4 and SiO2 particles were chosen as the test materials in the present study. Results: The cell viability data from an MTS assay showed that exposure to Fe3O4 or SiO2 particles at concentrations of 200 μg/mL and above significantly decreased the cell viability of HUVECs, but no significant loss in viability was observed in the THP-1 cells. TEM images indicated that with the accumulation of SiO2 particles in the cells, the size, structure and morphology of the lysosomes significantly changed in HUVECs, whereas the lysosomes of THP-1 cells were not altered. Our results showed that reactive oxygen species (ROS) generation; the production of interleukin (IL)-6, IL-8, monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor (TNF)-α and IL-1β; and the expression of CD106, CD62E and tissue factor in HUVECs and monocytes were significantly enhanced to a greater degree in the SiO2-particle-activated cocultures compared with the individual cell types alone. In contrast, exposure to Fe3O4 particles had no impact on the activation of monocytes or endothelial cells in monoculture or coculture. Moreover, using treatment with the supernatants of SiO2-particle-stimulated monocytes or HUVECs, we found that the enhancement of proinflammatory response by SiO2 particles was not mediated by soluble factors but was dependent on the direct contact between monocytes and HUVECs. Furthermore, flow cytometry analysis showed that SiO2 particles could markedly increase CD40L expression in HUVECs. Our data also demonstrated that the stimulation of cocultures with SiO2 particles strongly enhanced c-Jun NH2-terminal kinase (JNK) phosphorylation and NF-κB activation in both HUVECs and THP-1 cells, whereas the phosphorylation of p38 was not affected. Conclusions: Our data demonstrate that SiO2 particles can significantly augment proinflammatory and procoagulant responses through CD40–CD40L-mediated monocyte-endothelial cell interactions via the JNK/NF-κB pathway, which suggests that cooperative interactions between particles, endothelial cells, and monocytes may trigger or exacerbate cardiovascular dysfunction and disease, such as atherosclerosis and thrombosis. These findings also indicate that the monocyte-endothelial cocultures represent a sensitive in vitro model system to assess the potential toxicity of particles and provide useful information that may help guide the future design and use of inorganic particles in biomedical applications.
- 18 September 2012
- Published by Springer Nature in Particle and Fibre Toxicology
- Vol. 9 (1) , 36
Open AccessEnhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions
Background: Inorganic particles, such as drug carriers or contrast agents, are often introduced into the vascular system. Many key components of the in vivo vascular environment include monocyte-endothelial cell interactions, which are important in the initiation of cardiovascular disease. To better understand the effect of particles on vascular function, the present study explored the direct biological effects of particles on human umbilical vein endothelial cells (HUVECs) and monocytes (THP-1 cells). In addition, the integrated effects and possible mechanism of particle-mediated monocyte-endothelial cell interactions were investigated using a coculture model of HUVECs and THP-1 cells. Fe3O4 and SiO2 particles were chosen as the test materials in the present study. Results: The cell viability data from an MTS assay showed that exposure to Fe3O4 or SiO2 particles at concentrations of 200 μg/mL and above significantly decreased the cell viability of HUVECs, but no significant loss in viability was observed in the THP-1 cells. TEM images indicated that with the accumulation of SiO2 particles in the cells, the size, structure and morphology of the lysosomes significantly changed in HUVECs, whereas the lysosomes of THP-1 cells were not altered. Our results showed that reactive oxygen species (ROS) generation; the production of interleukin (IL)-6, IL-8, monocyte chemoattractant protein 1 (MCP-1), tumor necrosis factor (TNF)-α and IL-1β; and the expression of CD106, CD62E and tissue factor in HUVECs and monocytes were significantly enhanced to a greater degree in the SiO2-particle-activated cocultures compared with the individual cell types alone. In contrast, exposure to Fe3O4 particles had no impact on the activation of monocytes or endothelial cells in monoculture or coculture. Moreover, using treatment with the supernatants of SiO2-particle-stimulated monocytes or HUVECs, we found that the enhancement of proinflammatory response by SiO2 particles was not mediated by soluble factors but was dependent on the direct contact between monocytes and HUVECs. Furthermore, flow cytometry analysis showed that SiO2 particles could markedly increase CD40L expression in HUVECs. Our data also demonstrated that the stimulation of cocultures with SiO2 particles strongly enhanced c-Jun NH2-terminal kinase (JNK) phosphorylation and NF-κB activation in both HUVECs and THP-1 cells, whereas the phosphorylation of p38 was not affected. Conclusions: Our data demonstrate that SiO2 particles can significantly augment proinflammatory and procoagulant responses through CD40–CD40L-mediated monocyte-endothelial cell interactions via the JNK/NF-κB pathway, which suggests that cooperative interactions between particles, endothelial cells, and monocytes may trigger or exacerbate cardiovascular dysfunction and disease, such as atherosclerosis and thrombosis. These findings also indicate that the monocyte-endothelial cocultures represent a sensitive in vitro model system to assess the potential toxicity of particles and provide useful information that may help guide the future design and use of inorganic particles in biomedical applications.
- 16 March 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Nanobioscience
- Vol. 11 (4) , 336-340
Effect of Particle Size of Hydroxyapatite Nanoparticles on its Biocompatibility
Nano-particulate biomaterials have been used in clinical diagnosis and treatment, as drug carrier or in cosmetics because of their excellent performance properties. The toxicity and biocompatibility of nanoparticles (NPs), however, are always a focused concern for a doctor or a scientist. At present, there is almost no systemic evaluation standard or testing methods of safety for nanoparticles. In this study, two kinds of hydroxylapatite, (HAP) NPs with different particle sizes were selected. A number of biocompatibility tests in vivo or in vitro were conducted. They were cytotoxicity (MTT assay), genotoxicity (Ames, Mouse Lymphoma Mutagenesis Assay), and systemic toxicity (Acute and Subacute). The results indicated that, under the concentration of 100 mg/L, both HAP NPs could cause significant inhibition of cell growth. The size of NPs might have close tie with cell response. The mutagenic test in vitro was negative in this study. Histopathological findings showed that both kinds of HAP NPs could induce pseudotubercles in lung. Moreover, smaller size of nanoparticles resulted in a vacuolar degeneration of nephric tubule epithelium at 7 days post-intraveneous injection. The results implied that the size of NPs might play an important role in the biocompatibility of the materials. The kidney might be the main organ of discharge of nanoparticles from body.
- 16 March 2012
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Nanobioscience
- Vol. 11 (4) , 336-340
Effect of Particle Size of Hydroxyapatite Nanoparticles on its Biocompatibility
Nano-particulate biomaterials have been used in clinical diagnosis and treatment, as drug carrier or in cosmetics because of their excellent performance properties. The toxicity and biocompatibility of nanoparticles (NPs), however, are always a focused concern for a doctor or a scientist. At present, there is almost no systemic evaluation standard or testing methods of safety for nanoparticles. In this study, two kinds of hydroxylapatite, (HAP) NPs with different particle sizes were selected. A number of biocompatibility tests in vivo or in vitro were conducted. They were cytotoxicity (MTT assay), genotoxicity (Ames, Mouse Lymphoma Mutagenesis Assay), and systemic toxicity (Acute and Subacute). The results indicated that, under the concentration of 100 mg/L, both HAP NPs could cause significant inhibition of cell growth. The size of NPs might have close tie with cell response. The mutagenic test in vitro was negative in this study. Histopathological findings showed that both kinds of HAP NPs could induce pseudotubercles in lung. Moreover, smaller size of nanoparticles resulted in a vacuolar degeneration of nephric tubule epithelium at 7 days post-intraveneous injection. The results implied that the size of NPs might play an important role in the biocompatibility of the materials. The kidney might be the main organ of discharge of nanoparticles from body.